Here, we show that in RCC cells SC66 induced ROS production, SphK1 inhibition, ceramide accumulation and JNK activation, which does not occur in RCC cells treated with the AKT specific inhibitor MK-220635,41 or in AKT1-silenced/-KO RCC cells. Here, MAPK8 is linked to renal cell carcinoma.